No definition available.
Congenital absence, occlusion, or narrowing of the ear canal
Q17_CONGENITAL_ABSENCE_OCCLUSION_OR_NARROWING_OF_THE_EAR_CANAL
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
69 |
4. Check minimum number of eventsNone |
69 |
5. Include endpointsNone |
69 |
6. Filter based on genotype QC (FinnGen only) |
68 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Congenital absence, occlusion, or narrowing of the ear canal
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of ear causing impairment of hearing
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 68 | 38 | 30 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 25.44 | 17.37 | 35.65 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 69
- Matched controls
- 690
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q161, ,
ICD-10 Finland
Congenital absence, atresia and stricture of auditory canal (external)
+∞
99.1
69
*
A98, ,
ICD-O-3
+∞
93.7
67
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
70.2
55
*
WX110, ,
ICD-O-3
+∞
70.2
55
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
66.9
53
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
66.9
53
*
J01DB01, ,
ATC
cefalexin; oral
+∞
62.1
50
*
SAA01, ,
ICD-O-3
+∞
56.1
46
*
SAA02, ,
ICD-O-3
+∞
51.7
43
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
47.5
40
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
47.5
40
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
46.1
39
*
J069, ,
ICD-O-3
+∞
42.0
36
*
J01DA01, ,
ATC
[U] cefalexin
+∞
40.7
35
*
ZXD10, ,
ICD-O-3
+∞
40.7
35
*
ZXE00, ,
ICD-O-3
+∞
39.4
34
*
K021, ,
ICD-O-3
+∞
38.1
33
*
SFA10, ,
ICD-O-3
+∞
38.1
33
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
38.1
33
*
M03BX02, ,
ATC
tizanidine; oral
+∞
36.8
32
*
EB1AA, ,
ICD-O-3
+∞
36.8
32
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
36.8
32
*
SAA03, ,
ICD-O-3
+∞
35.5
31
*
ZXE10, ,
ICD-O-3
+∞
35.5
31
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
34.2
30
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
34.2
30
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
34.2
30
*
EB1HA, ,
ICD-O-3
+∞
34.2
30
*
EB1SA, ,
ICD-O-3
+∞
33.0
29
*
SFA20, ,
ICD-O-3
+∞
33.0
29
*
UDC00, ,
ICD-O-3
+∞
31.7
28
*
Z012, ,
ICD-O-3
+∞
30.5
27
*
WYA05, ,
ICD-O-3
+∞
29.2
26
*
GD1AA, ,
ICD-O-3
+∞
29.2
26
*
SCA01, ,
ICD-O-3
+∞
29.2
26
*
KMAK, ,
ICD-O-3
+∞
28.0
25
*
Z3231, ,
ICD-O-3
+∞
28.0
25
*
WX290, ,
ICD-O-3
+∞
28.0
25
*
E0000UV, ,
ATC
+∞
26.8
24
*
Z011, ,
ICD-10 Finland
Examination of ears and hearing
+∞
26.8
24
*
WZC00, ,
ICD-O-3
+∞
26.8
24
*
WZB00, ,
ICD-O-3
+∞
25.6
23
*
-1, ,
ICD-O-3
+∞
25.6
23
*
SPAT1253, ,
ICD-O-3
+∞
25.6
23
*
R05, ,
ICD-O-3
+∞
25.6
23
*
SPAT1263, ,
ICD-O-3
+∞
25.6
23
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
25.6
23
*
SPAT1256, ,
ICD-O-3
+∞
25.6
23
*
EBA00, ,
ICD-O-3
+∞
24.4
22
*
ZXA05, ,
ICD-O-3
+∞
24.4
22
*
S18, ,
ICD-O-3
+∞
24.4
22
*
Z2221, ,
ICD-O-3
+∞
24.4
22
*
R74, ,
ICD-O-3
+∞
24.4
22
*
R06AE07, ,
ATC
cetirizine; oral
+∞
24.4
22
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
23.2
21
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
23.2
21
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
23.2
21
*
ZXD05, ,
ICD-O-3
+∞
22.0
20
*
DFF00, ,
ICD-O-3
+∞
22.0
20
*
WX408, ,
ICD-O-3
+∞
22.0
20
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
22.0
20
*
Q172, ,
ICD-10 Finland
Microtia
+∞
22.0
20
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
22.0
20
*
R01AD09, ,
ATC
mometasone; nasal
+∞
22.0
20
*
VALMI, ,
ICD-O-3
+∞
20.9
19
*
D07AC01, ,
ATC
betamethasone; topical
+∞
20.9
19
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
20.9
19
*
H901, ,
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
20.9
19
*
SPAT1310, ,
ICD-O-3
+∞
20.9
19
*
R4110, ,
ICD-O-3
+∞
20.9
19
*
SPAT1301, ,
ICD-O-3
+∞
20.9
19
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
20.9
19
*
DBD20, ,
ICD-O-3
+∞
20.9
19
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
20.9
19
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
20.9
19
*
SDA02, ,
ICD-O-3
+∞
20.9
19
*
SPAT1249, ,
ICD-O-3
+∞
19.7
18
*
D82, ,
ICD-O-3
+∞
19.7
18
*
WX404, ,
ICD-O-3
+∞
19.7
18
*
R06AX27, ,
ATC
desloratadine; oral
+∞
19.7
18
*
K0364, ,
ICD-O-3
+∞
19.7
18
*
R21, ,
ICD-O-3
+∞
19.7
18
*
OAB43, ,
ICD-O-3
+∞
18.6
17
*
R5110, ,
ICD-O-3
+∞
18.6
17
*
SPAT1312, ,
ICD-O-3
+∞
18.6
17
*
TPH04, ,
ICD-O-3
+∞
18.6
17
*
WW200, ,
ICD-O-3
+∞
18.6
17
*
ZXE20, ,
ICD-O-3
+∞
17.4
16
*
R83, ,
ICD-O-3
+∞
17.4
16
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
17.4
16
*
I10, ,
ICD-O-3
+∞
17.4
16
*
H906, ,
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
+∞
17.4
16
*
Z760, ,
ICD-O-3
+∞
17.4
16
*
SPAT1325, ,
ICD-O-3
+∞
17.4
16
*
SBB10, ,
ICD-O-3
+∞
17.4
16
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
17.4
16
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
17.4
16
*
M796, ,
ICD-O-3
+∞
17.4
16
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
16.3
15
*
ZXA10, ,
ICD-O-3
+∞
16.3
15
*
Z718, ,
ICD-O-3
+∞
16.3
15
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
16.3
15
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
16.3
15
*
SDA03, ,
ICD-O-3
+∞
16.3
15
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
16.3
15
*
ZXA00, ,
ICD-O-3
+∞
16.3
15
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
16.3
15
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
15.1
14
*
C07AA05, ,
ATC
propranolol; systemic
+∞
15.1
14
*
K020, ,
ICD-O-3
+∞
15.1
14
*
Z871, ,
ICD-O-3
+∞
15.1
14
*
DAX00, ,
ICD-O-3
+∞
15.1
14
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
15.1
14
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
15.1
14
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
15.1
14
*
Z3226, ,
ICD-O-3
+∞
15.1
14
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
15.1
14
*
A97, ,
ICD-O-3
+∞
15.1
14
*
SPAT1315, ,
ICD-O-3
+∞
15.1
14
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
15.1
14
*
UJD10, ,
ICD-O-3
+∞
14.0
13
*
U072, ,
ICD-O-3
+∞
14.0
13
*
Z712, ,
ICD-O-3
+∞
14.0
13
*
EBA10, ,
ICD-O-3
+∞
14.0
13
*
SPAT1317, ,
ICD-O-3
+∞
14.0
13
*
D07AC13, ,
ATC
mometasone; topical
+∞
14.0
13
*
C10AA01, ,
ATC
simvastatin; oral
+∞
14.0
13
*
H900, ,
ICD-10 Finland
Conductive hearing loss, bilateral
+∞
14.0
13
*
D19, ,
ICD-O-3
+∞
14.0
13
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
14.0
13
*
M02AA07, ,
ATC
piroxicam; topical
+∞
14.0
13
*
SDA01, ,
ICD-O-3
+∞
14.0
13
*
WX402, ,
ICD-O-3
+∞
14.0
13
*
DC1AD, ,
ICD-O-3
+∞
14.0
13
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
12.9
12
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
12.9
12
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
12.9
12
*
R5140, ,
ICD-O-3
+∞
12.9
12
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
12.9
12
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
12.9
12
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
12.9
12
*
J209, ,
ICD-O-3
+∞
12.9
12
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
12.9
12
*
Q160, ,
ICD-10 Finland
Congenital absence of (ear) auricle
+∞
12.9
12
*
E000001, ,
ATC
+∞
12.9
12
*
K0365, ,
ICD-O-3
+∞
12.9
12
*
WZA90, ,
ICD-O-3
+∞
12.9
12
*
N05CF01, ,
ATC
zopiclone; oral
+∞
11.8
11
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
11.8
11
*
M255, ,
ICD-O-3
+∞
11.8
11
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
11.8
11
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
11.8
11
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
11.8
11
*
M545, ,
ICD-O-3
+∞
11.8
11
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
11.8
11
*
FM1EE, ,
ICD-O-3
+∞
11.8
11
*
GD1UA, ,
ICD-O-3
+∞
11.8
11
*
N05AH04, ,
ATC
quetiapine; oral
+∞
11.8
11
*
SDA04, ,
ICD-O-3
+∞
11.8
11
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
11.8
11
*
WX002, ,
ICD-O-3
+∞
10.7
10
*
R53, ,
ICD-O-3
+∞
10.7
10
*
J01DA08, ,
ATC
[U] cefaclor
+∞
10.7
10
*
JN3AE, ,
ICD-O-3
+∞
10.7
10
*
SPAT1363, ,
ICD-O-3
+∞
10.7
10
*
L03, ,
ICD-O-3
+∞
10.7
10
*
M54, ,
ICD-O-3
+∞
10.7
10
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
10.7
10
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
10.7
10
*
SPAT1283, ,
ICD-O-3
+∞
10.7
10
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
10.7
10
*
SFA30, ,
ICD-O-3
+∞
10.7
10
*
L309, ,
ICD-O-3
+∞
10.7
10
*
U071, ,
ICD-O-3
+∞
10.7
10
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
10.7
10
*
WX700, ,
ICD-O-3
+∞
10.7
10
*
SAB02, ,
ICD-O-3
+∞
10.7
10
*
SPAT1250, ,
ICD-O-3
+∞
10.7
10
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
10.7
10
*
SDE02, ,
ICD-O-3
+∞
10.7
10
*
S29, ,
ICD-O-3
+∞
10.7
10
*
Z3229, ,
ICD-O-3
+∞
10.7
10
*
J010, ,
ICD-O-3
+∞
10.7
10
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
10.7
10
*
MA2AE, ,
ICD-O-3
+∞
10.7
10
*
DBD30, ,
ICD-O-3
+∞
10.7
10
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
10.7
10
*
ND2AA, ,
ICD-O-3
+∞
9.6
9
*
N06AB04, ,
ATC
citalopram; systemic
+∞
9.6
9
*
H81, ,
ICD-O-3
+∞
9.6
9
*
OAA65, ,
ICD-O-3
+∞
9.6
9
*
WX320, ,
ICD-O-3
+∞
9.6
9
*
SBB00, ,
ICD-O-3
+∞
9.6
9
*
R238, ,
ICD-O-3
+∞
9.6
9
*
A10BA02, ,
ATC
metformin; oral
+∞
9.6
9
*
H13, ,
ICD-O-3
+∞
9.6
9
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
9.6
9
*
R104, ,
ICD-O-3
+∞
9.6
9
*
E7801, ,
ICD-O-3
+∞
9.6
9
*
SPAT1316, ,
ICD-O-3
+∞
9.6
9
*
L17, ,
ICD-O-3
+∞
9.6
9
*
SPAT1308, ,
ICD-O-3
+∞
9.6
9
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
9.6
9
*
SFA40, ,
ICD-O-3
+∞
9.6
9
*
C09AA05, ,
ATC
ramipril; oral
+∞
9.6
9
*
EB1MA, ,
ICD-O-3
+∞
9.6
9
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
9.6
9
*
SXC05, ,
ICD-O-3
+∞
9.6
9
*
SFA00, ,
ICD-O-3
+∞
9.6
9
*
H609, ,
ICD-10 Finland
Otitis externa, unspecified
+∞
9.6
9
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
9.6
9
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
9.6
9
*
Z363, ,
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
+∞
9.6
9
*
K045, ,
ICD-O-3
+∞
9.6
9
*
UJF32, ,
ICD-O-3
+∞
9.6
9
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
9.6
9
*
SAB03, ,
ICD-O-3
+∞
9.6
9
*
K0510, ,
ICD-O-3
+∞
9.6
9
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
9.6
9
*
SGA01, ,
ICD-O-3
+∞
8.5
8
*
LC2BE, ,
ICD-O-3
+∞
8.5
8
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
8.5
8
*
DFF15, ,
ICD-O-3
+∞
8.5
8
*
Z974, ,
ICD-10 Finland
Presence of external hearing-aid
+∞
8.5
8
*
K0366, ,
ICD-O-3
+∞
8.5
8
*
C08CA01, ,
ATC
amlodipine; oral
+∞
8.5
8
*
DAD10, ,
ICD-O-3
+∞
8.5
8
*
G473, ,
ICD-O-3
+∞
8.5
8
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
8.5
8
*
H608, ,
ICD-10 Finland
Other otitis externa
+∞
8.5
8
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
8.5
8
*
DEE00, ,
ICD-O-3
+∞
8.5
8
*
A03, ,
ICD-O-3
+∞
8.5
8
*
SAA04, ,
ICD-O-3
+∞
8.5
8
*
L12, ,
ICD-O-3
+∞
8.5
8
*
EBA05, ,
ICD-O-3
+∞
8.5
8
*
UKC02, ,
ICD-O-3
+∞
8.5
8
*
K85, ,
ICD-O-3
+∞
8.5
8
*
SPAT1223, ,
ICD-O-3
+∞
8.5
8
*
NG1AA, ,
ICD-O-3
+∞
8.5
8
*
AA1AD, ,
ICD-O-3
+∞
8.5
8
*
H01, ,
ICD-O-3
+∞
8.5
8
*
R103, ,
ICD-O-3
+∞
8.5
8
*
ZYC01, ,
ICD-O-3
+∞
8.5
8
*
W11, ,
ICD-O-3
+∞
8.5
8
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
8.5
8
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
8.5
8
*
D01BA02, ,
ATC
terbinafine; oral
+∞
8.5
8
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
8.5
8
*
SPAT1033, ,
ICD-O-3
+∞
8.5
8
*
SPAT1197, ,
ICD-O-3
+∞
8.5
8
*
N06AB06, ,
ATC
sertraline; oral
+∞
8.5
8
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
8.5
8
*
P01, ,
ICD-O-3
+∞
8.5
8
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
8.5
8
*
Z001, ,
ICD-O-3
+∞
8.5
8
*
SPAT1153, ,
ICD-O-3
+∞
8.5
8
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
8.5
8
*
W78, ,
ICD-O-3
+∞
8.5
8
*
Z113, ,
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
+∞
8.5
8
*
R03DC03, ,
ATC
montelukast; oral
+∞
8.5
8
*
N300, ,
ICD-O-3
+∞
8.5
8
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
8.5
8
*
MA1AE, ,
ICD-O-3
+∞
7.4
7
*
D07BA04, ,
ATC
hydrocortisone and antiseptics; topical
+∞
7.4
7
*
H907, ,
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
7.4
7
*
EMB10, ,
ICD-O-3
+∞
7.4
7
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
7.4
7
*
SPAT1306, ,
ICD-O-3
+∞
7.4
7
*
SAD01, ,
ICD-O-3
+∞
7.4
7
*
WZC10, ,
ICD-O-3
+∞
7.4
7
*
SPAT1254, ,
ICD-O-3
+∞
7.4
7
*
Z315, ,
ICD-10 Finland
Genetic counselling
+∞
7.4
7
*
N03AX16, ,
ATC
[U] pregabalin
+∞
7.4
7
*
WX704, ,
ICD-O-3
+∞
7.4
7
*
FM1AE, ,
ICD-O-3
+∞
7.4
7
*
S03CA04, ,
ATC
hydrocortisone and antiinfectives; ophthalmic, otic
+∞
7.4
7
*
W19, ,
ICD-10 Finland
Unspecified fall
+∞
7.4
7
*
Q161, ,
ICD-O-3
+∞
7.4
7
*
K0880, ,
ICD-O-3
+∞
7.4
7
*
E000002, ,
ATC
+∞
7.4
7
*
N05BA04, ,
ATC
oxazepam; oral
+∞
7.4
7
*
R06AE09, ,
ATC
levocetirizine; oral
+∞
7.4
7
*
MA2HE, ,
ICD-O-3
+∞
7.4
7
*
R03AK06, ,
ATC
salmeterol and fluticasone; inhalant
+∞
7.4
7
*
SPAT1262, ,
ICD-O-3
+∞
7.4
7
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
7.4
7
*
J45, ,
ICD-O-3
+∞
7.4
7
*
C09CA06, ,
ATC
candesartan; oral
+∞
7.4
7
*
DM1QA, ,
ICD-O-3
+∞
7.4
7
*
J209, ,
ICD-10 Finland
Acute bronchitis, unspecified
+∞
7.4
7
*
A23, ,
ICD-O-3
+∞
7.4
7
*
J350, ,
ICD-10 Finland
Chronic tonsillitis
+∞
7.4
7
*
A09, ,
ICD-O-3
+∞
7.4
7
*
MAX99, ,
ICD-O-3
+∞
7.4
7
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
7.4
7
*
N01, ,
ICD-O-3
+∞
7.4
7
*
AA1BG, ,
ICD-O-3
+∞
7.4
7
*
H613, ,
ICD-10 Finland
Acquired stenosis of external ear canal
+∞
7.4
7
*
P03, ,
ICD-O-3
+∞
7.4
7
*
SPAT1386, ,
ICD-O-3
+∞
7.4
7
*
SPAT1380, ,
ICD-O-3
+∞
7.4
7
*
OAB48, ,
ICD-O-3
+∞
7.4
7
*
R06AX13, ,
ATC
loratadine; oral
+∞
7.4
7
*
SFC01, ,
ICD-O-3
+∞
7.4
7
*
T90, ,
ICD-O-3
+∞
7.4
7
*
N05AH03, ,
ATC
olanzapine; systemic
+∞
7.4
7
*
FN1AC, ,
ICD-O-3
+∞
7.4
7
*
OAA80, ,
ICD-O-3
+∞
7.4
7
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
6.3
6
*
R06AX22, ,
ATC
ebastine; oral
+∞
6.3
6
*
EMB30, ,
ICD-O-3
+∞
6.3
6
*
SPAT1240, ,
ICD-O-3
+∞
6.3
6
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
6.3
6
*
CJE20, ,
ICD-O-3
+∞
6.3
6
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
6.3
6
*
B01AA03, ,
ATC
warfarin; systemic
+∞
6.3
6
*
DCA20, ,
ICD-O-3
+∞
6.3
6
*
Z392, ,
ICD-O-3
+∞
6.3
6
*
N06AB10, ,
ATC
escitalopram; oral
+∞
6.3
6
*
D07BB04, ,
ATC
hydrocortisone butyrate and antiseptics; topical
+∞
6.3
6
*
A04, ,
ICD-O-3
+∞
6.3
6
*
L28, ,
ICD-O-3
+∞
6.3
6
*
SPAT1379, ,
ICD-O-3
+∞
6.3
6
*
SJF01, ,
ICD-O-3
+∞
6.3
6
*
Z017, ,
ICD-O-3
+∞
6.3
6
*
ND1AA, ,
ICD-O-3
+∞
6.3
6
*
H02, ,
ICD-O-3
+∞
6.3
6
*
R600, ,
ICD-O-3
+∞
6.3
6
*
H612, ,
ICD-O-3
+∞
6.3
6
*
XF404, ,
ICD-O-3
+∞
6.3
6
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
6.3
6
*
X23, ,
ICD-O-3
+∞
6.3
6
*
Z304, ,
ICD-O-3
+∞
6.3
6
*
SDE03, ,
ICD-O-3
+∞
6.3
6
*
GD1PA, ,
ICD-O-3
+∞
6.3
6
*
SPAT1281, ,
ICD-O-3
+∞
6.3
6
*
WX400, ,
ICD-O-3
+∞
6.3
6
*
ZXD30, ,
ICD-O-3
+∞
6.3
6
*
7440A, ,
ICD-9 Finland
Congenital anomalies of ear, face and neck, Anomalies of ear causing impairment of hearing[ATRESIA AURIS]
+∞
6.3
6
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
6.3
6
*
M511, ,
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
+∞
6.3
6
*
H29, ,
ICD-O-3
+∞
6.3
6
*
Z461, ,
ICD-10 Finland
Fitting and adjustment of hearing aid
+∞
6.3
6
*
JN3BD, ,
ICD-O-3
+∞
6.3
6
*
F29, ,
ICD-O-3
+∞
6.3
6
*
K0382, ,
ICD-O-3
+∞
6.3
6
*
WX105, ,
ICD-O-3
+∞
6.3
6
*
R05, ,
ICD-10 Finland
Cough
+∞
6.3
6
*
TPH07, ,
ICD-O-3
+∞
6.3
6
*
J01MA14, ,
ATC
moxifloxacin; systemic
+∞
6.3
6
*
TQW40, ,
ICD-O-3
+∞
6.3
6
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
6.3
6
*
K409, ,
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
+∞
6.3
6
*
DAX08, ,
ICD-O-3
+∞
6.3
6
*
SPAT1307, ,
ICD-O-3
+∞
6.3
6
*
M751, ,
ICD-O-3
+∞
6.3
6
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
6.3
6
*
WX892, ,
ICD-O-3
+∞
6.3
6
*
J459, ,
ICD-O-3
+∞
6.3
6
*
ZZA00, ,
ICD-O-3
+∞
6.3
6
*
C08CA13, ,
ATC
lercanidipine; oral
+∞
6.3
6
*
OAB44, ,
ICD-O-3
+∞
6.3
6
*
XF400, ,
ICD-O-3
+∞
6.3
6
*
SCA02, ,
ICD-O-3
+∞
6.3
6
*
H669, ,
ICD-O-3
+∞
6.3
6
*
H653, ,
ICD-10 Finland
Chronic mucoid otitis media
+∞
6.3
6
*
IEY05, ,
ICD-O-3
+∞
6.3
6
*
D07XC01, ,
ATC
betamethasone; topical
+∞
6.3
6
*
L13, ,
ICD-O-3
+∞
6.3
6
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
6.3
6
*
Z301, ,
ICD-O-3
+∞
6.3
6
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
6.3
6
*
DM1AD, ,
ICD-O-3
+∞
6.3
6
*
N02CC01, ,
ATC
sumatriptan; nasal, systemic, rectal
+∞
6.3
6
*
KH1AE, ,
ICD-O-3
+∞
6.3
6
*
ZZG00, ,
ICD-O-3
+∞
6.3
6
*
112, ,
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
6.3
6
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
6.3
6
*
F510, ,
ICD-O-3
+∞
6.3
6
*
E780, ,
ICD-O-3
+∞
6.3
6
*
M01AG02, ,
ATC
tolfenamic acid; oral, rectal
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
10
45
2.43
1.55
1.6
2.5
—
—
—
0
0
5
116
0.39
1.42
1.0
1.4
—
—
—
0
0
45
519
0.62
1.02
3.5
3.7
—
—
—
0
0
17
232
0.65
0.78
3.2
3.0
66.67
72.34
nmol/l
0.64
17
209
5
90
0.52
0.73
1.4
8.0
0.84
0.82
mmol/l
—
5
80
5
26
1.99
0.72
1.2
1.3
—
—
—
0
0
16
211
0.69
0.60
3.4
6.2
38.14
37.51
g/l
0.25
16
202
47
513
0.74
0.48
3.4
3.9
2.83
2.73
mmol/l
0.32
47
479
47
510
0.75
0.43
3.1
3.7
4.79
4.57
mmol/l
0.92
47
478
21
252
0.76
0.42
2.2
2.8
—
—
—
0
0
0
15
0.00
0.42
0.0
2.3
—
—
—
0
0
0
15
0.00
0.42
0.0
2.2
—
—
—
0
0
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
47
509
0.76
0.41
3.0
3.6
1.51
1.44
mmol/l
0.56
47
473
0
16
0.00
0.41
0.0
2.2
—
—
—
0
0
0
16
0.00
0.41
0.0
2.4
—
8.47
—
0
16
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
2.9
—
—
—
0
0
15
187
0.75
0.38
2.3
3.8
24.47
32.22
u/l
1.51
15
173
5
78
0.61
0.38
1.8
7.6
3.20
6.82
umol/l
—
5
63
6
87
0.66
0.35
4.0
10.5
0.92
1.17
mmol/l
—
6
80
15
183
0.77
0.33
1.5
1.7
87.34
95.28
pmol/l
—
8
88
16
192
0.78
0.31
2.2
4.2
—
—
—
0
0
10
127
0.75
0.28
1.5
2.8
—
—
—
0
0
12
148
0.77
0.28
3.7
2.4
—
—
—
0
0
5
37
1.38
0.24
1.0
4.6
1.98
5.61
ug/l
—
5
27
16
187
0.81
0.24
1.4
1.5
0.34
1.45
u/ml
—
5
33
11
134
0.79
0.23
2.5
3.6
0.00
0.00
estimate
—
5
48
60
577
1.31
0.22
8.5
12.3
29.51
19.91
mg/l
0.82
45
420
0
11
0.00
0.21
0.0
3.5
—
0.00
—
0
11
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
3.5
—
0.00
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
3.3
—
0.00
—
0
12
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
25
276
0.85
0.20
1.8
3.5
0.00
0.00
estimate
—
5
49
25
273
0.87
0.17
2.6
5.0
0.00
0.00
estimate
—
5
50
7
89
0.76
0.15
1.9
1.9
—
—
—
0
0
18
197
0.88
0.11
18.7
8.0
1.63
1.19
inr
—
7
51
6
55
1.10
0.09
3.2
12.4
23.22
25.38
mmol/l
—
6
55
5
60
0.82
0.08
1.6
1.8
—
—
—
0
0
6
71
0.83
0.08
2.8
2.6
2.46
2.43
mmol/l
—
6
60
6
70
0.84
0.08
1.2
1.8
—
—
—
0
0
20
187
1.10
0.07
1.7
1.6
—
—
—
0
0
12
132
0.89
0.07
3.2
2.2
—
—
—
0
0
26
272
0.93
0.06
1.8
3.5
0.00
0.00
estimate
—
6
52
58
589
0.90
0.04
9.2
12.6
69.88
70.24
umol/l
0.04
58
589
30
310
0.94
0.04
2.8
5.2
6.22
6.34
mmol/l
0.17
25
283
47
476
0.96
0.00
8.1
10.1
93.52
94.79
ml/min/173m2
0.12
35
371
15
152
0.98
0.00
3.4
3.6
18.57
70.77
ng/l
—
7
83
20
195
1.04
0.00
2.0
3.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
8
86
0.92
0.00
1.6
1.9
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
30.45
—
0
8
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
5
51
0.98
-0.00
1.8
3.8
37.40
30.61
%
—
5
36
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
14.33
—
0
7
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
1.73
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
—
—
0
0
7
78
0.89
-0.00
1.4
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
44.37
—
0
7
0
6
0.00
-0.00
0.0
5.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
13.40
—
0
5
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
5
59
0.84
-0.00
2.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
5
58
0.85
-0.00
2.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
7.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
10.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_CONGENITAL_ABSENCE_OCCLUSION_OR_NARROWING_OF_THE_EAR_CANAL – Congenital absence, occlusion, or narrowing of the ear canal
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).